Lorena E. Brown

Induction of long-term memory CD8(+) T cells for recall of viral clearing responses against influenza virus.

Identification of antigenically active tryptic fragments of apical membrane antigen-1 (AMA1) of Plasmodium chabaudi malaria: strategies for assembly of immunologically active peptides.

Highly immunogenic and totally synthetic lipopeptides as self-adjuvanting immunocontraceptive vaccines.

Immune responses in hepatitis C virus infection: the role of dendritic cells.

Maturation of dendritic cells with lipopeptides that represent vaccine candidates for hepatitis C virus.

Single-cell perforin and granzyme expression reveals the anatomical localization of effector CD8+ T cells in influenza virus-infected mice.

Responses against complex antigens in various models of CD4 T-cell deficiency: surprises from an anti-CD4 antibody transgenic mouse.

A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses.

ISCOM-based vaccines: the second decade.

Lipid-based self-adjuvanting vaccines.

Targeting CD45RB alters T cell migration and delays viral clearance.

Intranasal lipopeptide primes lung-resident memory CD8+ T cells for long-term pulmonary protection against influenza.

Lipid-containing mimetics of natural triggers of innate immunity as CTL-inducing influenza vaccines.

Pandemic vaccines: promises and pitfalls.

Antiviral activity of the long chain pentraxin PTX3 against influenza viruses.

A self-adjuvanting lipopeptide-based vaccine candidate for the treatment of hepatitis C virus infection.

Targeting subcapsular antigens for prevention of Klebsiella pneumoniae infections.

Selected Toll-like receptor ligands and viruses promote helper-independent cytotoxic T cell priming by upregulating CD40L on dendritic cells.

Prospects for an influenza vaccine that induces cross-protective cytotoxic T lymphocytes.

Single dose intranasal immunization with ISCOMATRIX vaccines to elicit antibody-mediated clearance of influenza virus requires delivery to the lower respiratory tract.

Lipopeptide vaccines illustrate the potential role of subtype-crossreactive T cells in the control of highly virulent influenza.

Q&A: What have we found out about the influenza A (H1N1) 2009 pandemic virus?

Influenza A virus facilitates Streptococcus pneumoniae transmission and disease.

A lipopeptide based on the M2 and HA proteins of influenza A viruses induces protective antibody.

Potent immunity to low doses of influenza vaccine by probabilistic guided micro-targeted skin delivery in a mouse model.

Role of CD8(+) T-cell immunity in influenza infection: potential use in future vaccine development.

A phase I clinical trial of dendritic cell immunotherapy in HCV-infected individuals.

The role of adjuvants in vaccines for seasonal and pandemic influenza.

Prevention and treatment of influenza with hyperimmune bovine colostrum antibody.

Improving the reach of vaccines to low-resource regions, with a needle-free vaccine delivery device and long-term thermostabilization.

The role of neutrophils during mild and severe influenza virus infections of mice.

The linear range for accurately quantifying antigen-specific T-cell frequencies by tetramer staining during natural immune responses.

Rapid kinetics to peak serum antibodies is achieved following influenza vaccination by dry-coated densely packed microprojections to skin.

Nanopatch targeted delivery of both antigen and adjuvant to skin synergistically drives enhanced antibody responses.